30DEC

Libyan International Conference for Health Sciences

The First Libyan International Conference for Health Sciences (2024): Open University, Tripoli, Libya
Mediterranean Journal of Pharmacy and Pharmaceutical Sciences
https://ppj.org.ly/article/doi/10.5281/zenodo.7877416

Mediterranean Journal of Pharmacy and Pharmaceutical Sciences

Original article

Prevalence of cardiovascular risk factors in Libyan patients with type 2 diabetes mellitus, 2013-2022

Samia A. Elmiladi, Elham O. Elgdhafi

Downloads: 2
Views: 254

Abstract

Cardiovascular disease (CVD) remains the leading reason of death among patients with diabetes mellitus (DM). Individuals with DM have a two to five times greater risk of developing CVD than non-DM. Unfortunately, little data exists on Libya's prevalence and characteristics of cardiovascular risk factors. This study aimed to evaluate the cardiovascular risk factors and assess their control among patients with type 2 DM (T2DM). All the patients with T2DM who attended the outpatient clinic at the National Diabetes Hospital from September 2013 to April 2022 were interviewed and examined and included in this study. Demographical data age, smoking habit, body mass index measure, drug intake, history of previous cardiovascular events, blood pressure and fasting lipid profile were all recorded. 1049 patients have completed the study with a mean age of 54.06±14.5 years old (females represented 68.0% of the studied sample size), there were different durations of diabetes between the studied sample, varying from newly diagnosed patients (n=265, 25.2%) and above ten years of diabetes duration patients (n=488, 46.5%). Active smoking in 129 patients (12.3%), the bodyweight of studied patients ranged from 44.0 Kg to 186 Kg (85.65±1.73), 820 of the patients had uncontrolled body weight (78.85%). Uncontrolled blood pressure, even with treatment, was found in 304 patients (29.0%), uncontrolled dyslipidaemia in 45 patients (04.3%), and uncontrolled hyperglycaemia in 816 patients (77.9%). Established CVD was positive in 295 patients (28.2%), maximum age group was 54-74 years (n=516, 49.3%). The most typical age group with multiple (more than three) CVD risk factors was 54-74 years of age, were female patients with more than ten years of history of diabetes, uncontrolled hyperglycemia (HBA1c >10%), uncontrolled body weight, uncontrolled blood pressure and dyslipidemia. Thus, the present data indicated that Libyan patients with diabetes mellitus have high CVD risk factors. Even in patients with previous events, these uncontrolled risk factors elevate the likelihood of repeated cardiovascular events. Patients with diabetes mellitus necessitate a more aggressive approach to control the modified risk factors such as hypertension, dyslipidemia, obesity and smoking. 

Keywords

Cardiovascular disease, diabetes mellitus, hypertension, prevalence, obesity 

References

  1. Preis SR, Hwang SJ, Coady S, Pencina MJ, D’Agostino Sr RB, Savage PJ, Levy PJ, Fox CS (2009) Trends in all-cause and cardiovascular disease mortality among women and men with and without diabetes mellitus in the Framingham Heart Study, 1950 to 2005. Circulation. 119 (13): 728-1735. doi: 10.1161/CIRCULATIONAHA. 108.829176
  2. Gregg EW, Cheng YJ, Saydah S, Cowie C, Garfield S, Geiss L, Barker L (2012) Trends in death rates among US adults with and without diabetes between 1997 and 2006: findings from the National Health Interview Survey. Diabetes Care. 35 (6): 1252-1257. doi: 10.2337/dc11-1162
  3. Morrish NJ, Wang SL, Stevens LK, Fuller JH, Keen H (2001) Mortality and causes of death in the WHO multinational study of vascular disease in diabetes. Diabetologia. 44 (Suppl. 2): S14-S21. doi: 10.1007/pl00002934
  4. Haffner SM, Lehto S, Rönnemaa T, Pyörälä K, Laakso M (1998) Mortality from coronary heart disease in subjects with type 2 diabetes and non-diabetic subjects with and without prior myocardial infarction. The New England Journal of Medicine. 339 (4): 229-234. doi: 10.1056/NEJM199807233390404
  5. Bulugahapitiya U, Siyambalapitiya S, Sithole J, Idris I (2009) Is diabetes a coronary risk equivalent? Systematic review and meta-analysis. Diabetic Medicine. 26 (2): 142-148. doi: 10.1111/j.1464-5491. 2008.02640.x
  6. Gu K, Cowie CC, Harris MI (1998) Mortality in adults with and without diabetes in a national cohort of the US population, 1971-1993. Diabetes Care. 21 (7): 1138-1145. doi: 10.2337/diacare.21.7.1138
  7. Bonadonna RC, Cucinotta D, Fedele D, Riccardi G, Tiengo A (2006) The metabolic syndrome is a risk indicator of microvascular and macrovascular complications in diabetes: results from meta screen, a multicenter diabetes clinic-based survey. Diabetes Care. 29 (12): 2701-2707. doi: 10.2337/dc06-0942
  8. NCD Management-Screening, Diagnosis and Treatment (2016) Global report on diabetes. World Health Organization. 83. ISBN9789241565257.
  9. Gregg EW, Zhuo X, Cheng YJ, Albright AL, Narayan KM, Thompson TJ (2014) Trends in lifetime risk and years of life lost due to diabetes in the USA, 1985-2011: a modeling study. Lancet Diabetes Endocrinology. 2 (11): 867-874. doi: 10.1016/S2213-8587(14)70161-5
  10. Peters SAE, Huxley RR, Woodward M (2014) Diabetes as a risk factor for incident coronary heart disease in women compared with men: a systematic review and meta-analysis of 64 cohorts including 858,507 individuals and 28,203 coronary events. Diabetologia. 57 (8): 1542-1551. doi: 10.1007/s00125-014-3260-6
  11. Lee WL, Cheung AM, Cape D, Zinman B (2000) Impact of diabetes on coronary artery disease in women and men: a meta-analysis of prospective studies. Diabetes Care. 23 (7): 962-968. doi: 10.2337/diacare.23.7.962
  12. Hussein A, Mahmoud SED, Awad MS (2020) Assessment of cardiovascular risk factors in patients with type 2 diabetes in Upper Egypt Villages. Diabetes, Metabolic Syndrome and Obesity. 13: 4737-4746. doi: Nil.
  13. Al-Delaimy WK, Manson JE, Solomon CG, Kawachi I, Stampfer MJ, Willett WC, Hu FB (2002) Smoking and risk of coronary heart disease among women with type 2 diabetes mellitus. Archives of Internal Medicine. 162 (3): 273-279. doi: 10.1001/archinte.162.3.273
  14. King P, Peacock I, Donnelly R (1999) The UK Prospective Diabetes Study (UKPDS): clinical and therapeutic implications for type 2 diabetes. British Journal of Clinical Pharmacology. 48 (5): 643-648. doi: 10.1046/j.1365-2125.1999.00092.x
  15. Glynn RJ, L'Italien GJ, Sesso HD, Jackson EA, Buring JE (2002) Development of predictive models for long-term cardiovascular risk associated with systolic and diastolic blood pressure. Hypertension. 39 (1): 105-110. doi: 10.1161/hy1201.097199
  16. Afandi B, Ahmad S, Saadi H, Elkhumaidi S, Karkoukli MA, Kelly B, Assaf H, Matear D (2006) Audit of a diabetes clinic at Tawam Hospital, United Arab Emirates, 2004-2005. Annals of the New York Academy Sciences. 1084 (1): 319-324. doi. 10.1196/annals.1372.017
  17. Al Slail FY, Abid O, Assiri AM, Memish ZA, Ali MK (2016) Cardiovascular risk profiles of adults with type-2 diabetes treated at urban hospitals in Riyadh, Saudi Arabia. Journal of Epidemiology and Global Health. 6 (1): 29-36. doi: 10.1016/j.jegh.2015.07.004
  18. American Diabetes Association (2004) Standards of medical care in diabetes. Diabetes Care. 27 (Suppl 1): e15-e35. doi.org/10.2337/diacare.27.2007.S15
  19. Gebreegziabiher G, Belachew T, Mehari K, Tamir D (2021) Prevalence of dyslipidemia and associated risk factors among adult residents of Mekelle City, Northern Ethiopia. PLoS One. 16 (2): e0243103. doi: 10.1371/journal. pone.0243103
  20. Hirbli KI, Jambeine MA, Slim HB, Barakat WM, Habis RJ, Francis ZM (2005) Prevalence of diabetes in greater Beirut. Diabetes Care. 28 (5): 1262. doi: 10.2337/diacare.28.5.1262
  21. Kharal M, Al-Hajjaj A, Al-Ammri M, Mardawi G, Tamim HM, Bin Salih S, Yousuf M (2010) Meeting the American Diabetic Association standards of diabetic care. Saudi Journal of Kidney Diseases and Transplantation. 21 (4): 678-685. doi: Nil.
  22. Bryant W, Greenfield JR, Chisholm DJ, Campbell LV (2006) Diabetes guidelines: easier to preach than to practice? Medical Journal of Australia. 185 (6): 305-309. doi: 10.5694/j.1326-5377.2006.tb00583.x
  23. Khaw KT, Wareham N, Bingham S, Luben R, Welch A, Day N (2004) Association of hemoglobin A1c with cardiovascular disease and mortality in adults: The European prospective investigation into cancer in Norfolk. Annals of Internal Medicine. 141 (6): 413-420. doi: 10.7326/0003-4819-141-6-200409210-00006
  24. Rodriguez BL, Lau N, Burchfiel CM, Abbott RD, Sharp DS, Curb JD (1999) Glucose intolerance and 23-year risk of coronary heart disease and total mortality: The Honolulu Heart Program. Diabetes Care. 22: 1262-1265.
  25. Bawady N, Aldafrawyb O, ElZobair EM, Suliman W, Alzaabi A, Ahmed SH (2022) Prevalence of overweight and obesity in type 2 diabetic patients visiting PHC in the Dubai Health Authority. Dubai Diabetes and Endocrinology Journal. 28: 20-24. doi. 10.1159/000519444
  26. Alhazmi RS, Ahmed AAB, Alshalan MH, Alfuhigi ZD, Alhazmi SF, Aldughmi AN, Alshammari NN, Alruwaili AE, Alenezi GS, Alanazi TS, Shouq Amjad Almadani SA (2017) Prevalence of diabetes mellitus and its relation with obesity in Turaif (Saudi Arabia) in 2017. Electronic Physician. 9 (10): 5531-5535.  doi: 10.19082/5531
  27. Lin FJ, Tseng WK, Yin WH, Yeh H-I, Chen J-W, Wu C-C (2017) Residual risk factors to predict major adverse cardiovascular events in atherosclerotic cardiovascular disease patients with and without diabetes mellitus. Scientific Reports. 7 (1): 9179. doi: 10.1038/s41598-017-08741-0

Submitted date:
04/08/2023

Reviewed date:
04/24/2023

Accepted date:
04/28/2023

Publication date:
07/20/2023

64b99dfea953956f051ae183 medjpps Articles
Links & Downloads

Mediterr J Pharm Pharm Sci

Share this page
Page Sections